Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort
Hu, Xichun; Zhang, Qingyuan; Sun, Tao; Xiong, Huihua; Li, Wei; Teng, Yuee; Lu, Yen-Shen; Tseng, Ling-Ming; Yan, Min; Li, Hongsheng; Pang, Danmei; -Chen, Shin-Cheh; Chen, Wenyan; Jiang, Ou; Wang, Jingfen; Wu, Xinhong; Wang, Xian; Zang, Aimin; Wang, Xiaojia; Collins, Julie M.; Fan, Ethan; Jiang, Lin; Zeng, Xiaoling; Turner, Nicholas C. Share Save Evaluation of the ameliorative role of soil amendments and selenium on morphophysiological traits, oxidative stress, and quality attributes of wheat (Triticum aestivum L.) under varying drought stress conditionsDing, Mingliang; Kong, Yunxin; Liu, Jia; Li, Hongsheng; Li, Shaoxiang; Yang, Yan; Zhang, Cuiping; Xiao, Chigui; Rehman, Muzammal; Maqbool, Zahid; Fan, Guiqiang; Liu, Kun; Zeng, Chaowu Share Save Share Save Bireociclib plus fulvestrant for HR+/HER2-advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysisWang, Jiayu; Zhang, Qingyuan; Li, Huiping; Tong, Zhongsheng; Ouyang, Quchang; Li, Huihui; Teng, Yuee; Wang, Biyun; Sun, Tao; Wang, Jingfen; Li, Wei; Niu, Zhaofeng; Li, Hongsheng; Gong, Chang; Wang, Shu; Wang, Xinshuai; Wu, Xinhong; Liu, Ning; Yu, Guohua; Liu, Fei; Duan, Xianghui; Wang, Shuya; Meng, Yaping; Wang, Li Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
